Burjeel Holdings announced that it has received its first corporate credit ratings from both S&P Global Ratings and Moody’s Ratings, while also establishing a USD 1.5 billion Senior Unsecured Sukuk Programme to support future growth and funding diversification.
The company stated that the milestone reflects Burjeel’s strong market position, disciplined financial management, robust corporate governance and commitment to transparency.
Key highlights:
• S&P assigned Burjeel a BB+ issuer credit rating with a Stable outlook
• Moody’s assigned Burjeel a Ba2 corporate family rating with a Stable outlook
• Established a USD 1.5 billion Senior Unsecured Sukuk Programme
• Sukuk programme admitted to the London Stock Exchange’s International Securities Market
• Provides a Shariah-compliant platform to access debt capital markets
• Supports funding diversification and long-term capital structure optimisation
According to S&P Global Ratings, the BB+ rating reflects Burjeel’s position as one of the UAE’s largest healthcare providers, the defensive nature of the healthcare sector, disciplined financial policies and expectations of improving profitability as growth assets mature.
Moody’s noted that the Ba2 rating reflects Burjeel’s strong market position in Abu Dhabi, expanding footprint across the UAE, Saudi Arabia and Oman, solid profitability, growing contribution from complex care and super-specialty services, and improving liquidity profile.
The Sukuk Programme has been established through Burjeel Sukuk Limited and is designed to support strategic investments in:
• Advanced clinical care
• Medical research
• Medical education
• Digital transformation initiatives
• AI-enabled healthcare innovation
Burjeel also announced that it has commenced fixed-income investor meetings with regional and international investors regarding a potential inaugural 5-year USD-denominated Sukuk issuance, subject to market conditions and regulatory approvals.
Chairman and CEO Dr. Shamsheer Vayalil described the ratings and Sukuk Programme as a major milestone that strengthens Burjeel’s financial flexibility and supports its vision of combining exceptional patient care with research, education and artificial intelligence-driven healthcare innovation.
Source: Burjeel Holdings
Disclaimer: This post is for informational purposes only and should not be considered investment or financial advice.